Glycogen Branching Enzyme 1 (GBE1) is an enzyme pivotal in the glycogenesis pathway, where it catalyzes the formation of α-1,6-glycosidic branches from α-1,4-glycosidic chains in glycogen. This branching process is crucial for the solubility and compactness of glycogen, thereby enhancing its availability as an energy source. GBE1's function is essential for proper glycogen storage, influencing the energy metabolism in various tissues, particularly in liver and muscle cells. The activity of this enzyme ensures the efficient and rapid mobilization of glucose when it is needed, highlighting its importance in maintaining glucose homeostasis. The regulation of glycogen synthesis and degradation, facilitated by GBE1, plays a significant role in metabolic responses to physiological demands, including physical activity and fasting.
The activation mechanisms of GBE1 involve a complex interplay of allosteric regulation, post-translational modifications, and interactions with other proteins in the glycogen synthesis pathway. Allosteric regulation, through which the enzyme's activity is modulated by its substrates or other metabolites, is a key aspect of its functional control. This ensures that GBE1 activity is closely coordinated with the cellular energy status, enhancing glycogen synthesis when glucose is abundant and slowing it down when energy demand is low. Post-translational modifications, such as phosphorylation, can alter the enzyme's activity by modulating its conformation or its interactions with glycogenin, the primer protein for glycogen synthesis. Furthermore, the activity of GBE1 is also influenced by its interaction with other enzymes involved in glycogen metabolism, such as glycogen synthase and phosphorylase, ensuring a fine-tuned regulation of glycogen synthesis and degradation. This intricate regulatory network allows GBE1 to efficiently respond to changes in cellular energy needs, playing a critical role in energy metabolism and homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates various pathways to promote glycogen synthesis. GBE1 can be influenced by changes stemming from insulin's actions. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
Elevated glucose levels in cells promote glycogenesis, potentially increasing the activity of enzymes involved, including GBE1. | ||||||
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
High ATP levels signal energy abundance and can indirectly influence glycogen synthesis pathways and enzymes like GBE1. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
A known AMPK activator which can influence cellular metabolism, potentially affecting glycogen synthesis and GBE1 indirectly. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, influencing energy homeostasis and possibly glycogen synthesis pathways and enzymes like GBE1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels potentially affecting several metabolic pathways that might impact GBE1's activity indirectly. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can influence glucose metabolism and thus potentially the activity of GBE1 indirectly. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPARγ agonist that modifies glucose metabolism and could, in turn, influence the activity of GBE1. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
Another PPARγ agonist, impacts glucose homeostasis and might indirectly modulate GBE1's activity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A PPARγ agonist that affects glucose metabolism which could have indirect effects on GBE1 activity. | ||||||